Malignant Tumor

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours

Multimodal Prehabilitation for Tumor-Related Bowel Obstruction

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2

Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

Rehabilitation Outcomes Study

Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease

Effectiveness of Central Oncology Navigation and the Use of an ORN

A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors

A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors

Impact of Family-Centered Empowerment on Caregivers of Children with Cancer: a Quasi-Experimental Study Protocol